Long-Acting Antiretrovirals: Benefits and Challenges in 2020
June 9, 2020
12:30 PM - 1:30 PM
Please join us for a live webinar on "Long-Acting Antiretrovirals: Benefits and Challenges in 2020" presented by Dr. Sarah Michienzi, PharmD, BCPS, AAHIVP. This presentation is hosted by the Midwest AIDS Training and Education Center (MATEC).
Registration is required (see registration link below). For more event information, click here.
____________________________________________________________________________________________________________________________________
Type of Activity: Knowledge-Based Target Audience: Pharmacists, Physicians, Physician Assistants, and Advanced Practice Nurses
Speaker:
Sarah Michienzi, PharmD, BCPS, AAHIVP
Clinical Assistant Professor and Clinical Pharmacist
University of Illinois at Chicago College of Pharmacy
____________________________________________________________________________________________________________________________________
Agenda:
Time: Program Title
12:30 pm - 1:30 pm Long-Acting Antiretrovirals: Benefits and Challenges in 2020
Learning Objectives:
At the completion of this activity, the participant will be able to:
- Describe the data supporting use of long-acting cabotegravir/rilpivirine (LA CAB/RPV) for treatment of HIV
- List steps required before starting a patient on LA CAB/RPV
- Discuss risk/benefits of LA CAB/RPV vs. conventional treatment during the pandemic
Fees: There is no charge for attending this activity
Disclosure: Dr. Michienzi and the reviewers who contributed to this activity have no relevant financial relationships of interest to disclose.
Date posted
May 14, 2020
Date updated
May 27, 2020